Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-10-06
2010-10-05
Long, Scott (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S063000
Reexamination Certificate
active
07807648
ABSTRACT:
The present invention relates to oligonucleotide compositions and therapeutic uses thereof to modify protein-protein interactions. In particular, the invention relates to the use of a guanidine-rich oligonucleotides to disrupt disease-causing protein aggregates, for example, Huntington's Disease (HD) protein aggregates.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: WO97/03997 (1997-06-01), None
Harper et al. PNAS. Apr. 19, 2005. vol. 102; No. 16: pp. 5820-5825.
Pisetsky et al (Immunopharmacology 40(1998) 199-208).
Evert et al. Cell and Tissue Research. Jun. 2000; 301(1): 189-204.
Skogen et al. (BCM Neuroscience 2006, 7(65): 1-16).
Dapić et al. (Nucleic Acids Research. 2003; 31(8): 2097-2107).
Jeffers et al. (Expert Opin. Ther. Targets. 2002; 6(4): 469-482).
Patil et al. (The AAPS Journal. 2005; 7(1) Article 9: E61-E77).
Biyani, M., et al. “Structural Characterization of Ultra-Stable Higher-Ordered Aggregates Generated By Novel Guanine-Rich DNA Sequences”; Gene 364 (2005); pp. 130-138.
Bates, Paula J., et al. “Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding”; The Journal of Biological Chemistry; vol. 274, No. 37, Sep. 10, 1999; pp. 26369-26377.
Dapic, V., et al. Antiproliferative Activity of G-Quartet-Forming Oligonucleotides with Backbone and Sugar Modifications; Biochemistry 2002, 41; pp. 3676-3685.
Xu, X., et al., “Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides”; The Journal of Biological Chemistry; vol. 276, No. 46, Nov. 16, 2001; pp. 43221-43230.
Kmiec Eric B.
Parekh-Olmedo Hetal
Long Scott
McCarter & English
University of Delaware
LandOfFree
G-rich polynucleotides for the treatment of Huntington's... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with G-rich polynucleotides for the treatment of Huntington's..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and G-rich polynucleotides for the treatment of Huntington's... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168216